Wellgistics health (nasdaq:wgrx) accelerates platform growth in q2 with 116 manufacturer partnerships, 12,400+ new products, and 275+ pharmacies added to its expanding tech based drug ecosystem

Tampa, fl / access newswire / june 25, 2025 / wellgistics health, inc. (nasdaq:wgrx), a healthcare technology company focused on building the future of prescription access and distribution, today announced significant q2 2025 operational results-adding 116 new pharmaceutical manufacturer partnerships, over 12,400 new products (ndcs), and 275+ pharmacies to its national platform. this expansion reflects wellgistics' accelerating momentum in creating a modern drug ecosystem-one that aims to connect manufacturers directly to pharmacies, providers, employers, and patients through a fully integrated, ai-powered infrastructure designed to streamline fulfillment, reduce costs, and bypass legacy bottlenecks.
WGRX Ratings Summary
WGRX Quant Ranking